Track the 3SBio Inc. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Market capitalisation: €6.6bn. The latest transaction was filed on 7 September 2026 (Purchase). Among the most active insiders: Lou Jing. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3SBio Inc. es una empresa biofarmacéutica china centrada en la investigación, desarrollo y comercialización de productos biológicos. Se dirige principalmente a tratamientos para enfermedades renales y trastornos sanguíneos.